Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays

Journal of Clinical Microbiology

Volumn 39, Issue 12, 2001, Pages 4452-4455

  Coenye, T ^a   Liu, L ^a   Vandamme, P ^a   Lipuma, J J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOSOME DNA; RNA 16S;

ARTICLE; BACTERIAL INFECTION; BACTERIUM; BACTERIUM IDENTIFICATION; CYSTIC FIBROSIS; DNA SEQUENCE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDORAEA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPUTUM ANALYSIS;

BACTERIAL TYPING TECHNIQUES; BETAPROTEOBACTERIA; CYSTIC FIBROSIS; DNA PRIMERS; DNA, RIBOSOMAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 0035208858     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.12.4452-4455.2001     Document Type: Article

References (15)

1. Microbiology of sputum from patients at cystic fibrosis centers in the United States
2. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov.
3. Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies
4. Microbiology of airway disease in patients with cystic fibrosis
5. Biochemical and molecular approaches for determining genomovar status of the Burkholderia cepacia complex
6. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative, nonfermenting bacilli recovered from patients with cystic fibrosis
7. Burkholderia cepacia: Management issues and new insights
8. Burkholderia cepacia epidemiology and pathogenesis: Implications for infection control
9. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients
10. Misidentification of Burkholderia cepacia in U.S. cystic fibrosis treatment centers: An analysis of 1051 recent sputum isolates
11. First report of Pandoraea norimbergensis isolated from food-potential clinical significance
12. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture
13. Species-specific PCR as a tool for the identification of Burkholderia gladioli
14. Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR
15. Identification of members of the Burkholderia cepacia complex by species-specific PCR